Forte Biosciences (FBRX) Retained Earnings (2016 - 2020)
Historic Retained Earnings for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to -$46.9 million.
- Forte Biosciences' Retained Earnings rose 8255.32% to -$46.9 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$46.9 million, marking a year-over-year increase of 8255.32%. This contributed to the annual value of -$5.0 million for FY2019, which is 9769.78% up from last year.
- Per Forte Biosciences' latest filing, its Retained Earnings stood at -$46.9 million for Q3 2020, which was up 8255.32% from -$41.8 million recorded in Q2 2020.
- Over the past 5 years, Forte Biosciences' Retained Earnings peaked at -$5.0 million during Q4 2019, and registered a low of -$289.7 million during Q1 2020.
- In the last 5 years, Forte Biosciences' Retained Earnings had a median value of -$173.4 million in 2017 and averaged -$166.1 million.
- Over the last 5 years, Forte Biosciences' Retained Earnings had its largest YoY gain of 9769.78% in 2019, and its largest YoY loss of 3695.52% in 2019.
- Quarter analysis of 5 years shows Forte Biosciences' Retained Earnings stood at -$128.0 million in 2016, then crashed by 30.41% to -$166.9 million in 2017, then dropped by 29.33% to -$215.9 million in 2018, then surged by 97.7% to -$5.0 million in 2019, then plummeted by 843.66% to -$46.9 million in 2020.
- Its Retained Earnings stands at -$46.9 million for Q3 2020, versus -$41.8 million for Q2 2020 and -$289.7 million for Q1 2020.